Clinuvel Pharmaceuticals Limited
CUV.AX
Price:
$9.575
Market Cap:
$482.68M
Clinuvel Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of treatments for patients battling genetic, metabolic, and life-threatening conditions. Its reach extends across Australia, Europe, the United States, Switzerland, and other global markets. The company's flagship drug, SCENESSE, serves as a systemic photoprotective treatment intended to prevent phototoxicity in adult patients diagnosed with erythropoietic protoporphyria (EPP). Clinuvel's development pipeline includes CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which promotes prolonged cellular activity; and PRÉNUMBRA, a liquid injectable...[Read more]
Industry
Biotechnology
IPO Date
2001-02-11
Stock Exchange
ASX
Ticker
CUV.AX
PE Ratio
[14.96]
ROE
[13.29%]
Current Ratio
[14.64]
Dividend Yield
[0.52%]
Enterprise Value
[446.89M]
Dividend History
CUV.AX Dividend History Overview
Dividends are a key part of long-term returns for investors, and Clinuvel Pharmaceuticals Limited (CUV.AX) has a track record worth reviewing. Looking at dividend history for CUV.AX gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2025-09-04
Dividend Yield
0.52%
Annual Dividend
$0.05
P/E Ratio
14.96
Payout Ratio
0.08
Dividend per Share
$0.05
EPS
0.64
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2025-09-04 | $0.05 | $0.05 | 2025-09-19 | |
| 2024-09-05 | $0.05 | $0.05 | 2024-09-20 | 2024-09-06 |
| 2023-09-05 | $0.05 | $0.05 | 2023-09-20 | |
| 2022-09-06 | $0.04 | $0.04 | 2022-09-21 | |
| 2021-09-02 | $0.025 | $0.025 | 2021-09-17 | |
| 2020-09-03 | $0.025 | $0.025 | 2020-09-18 | 2020-08-27 |
| 2019-09-04 | $0.025 | $0.025 | 2019-09-19 | 2019-08-28 |
| 2018-09-21 | $0.02 | $0.02 | 2018-10-08 | 2018-08-29 |
Clinuvel Pharmaceuticals Limited (CUV.AX) Dividend History Chart
The table below shows Clinuvel Pharmaceuticals Limited (CUV.AX) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Clinuvel Pharmaceuticals Limited (CUV.AX) Dividend Growth
Clinuvel Pharmaceuticals Limited (CUV.AX) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Australian Clinical Labs Limited (ACL.AX) | 0.06% |
| Cogstate Limited (CGS.AX) | 0.01% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Clinuvel Pharmaceuticals Limited (CUV.AX) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is CUV.AX’s dividend yield?
What is the difference between regular and special dividends?
Has CUV.AX increased its dividends over time?
Why might dividend history data be delayed?
How often does CUV.AX pay dividends?
What factors impact CUV.AX's dividend payments?
Can dividends change over time?
What is CUV.AX’s next dividend date?